XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets:    
Cash and cash equivalents $ 17,197 $ 9,408
Investments 2,792 3,117
Accounts receivable, net 26,317 24,431
Inventories 18,058 17,760
Assets held for sale 1,498 0
Other current assets 2,479 5,292
Total current assets 68,341 60,008
Long-term investments 20,565 23,025
Property and equipment, net 12,626 12,896
Operating lease right-of-use assets 18,270 19,122
Goodwill 78,086 79,121
Intangible assets, net 25,157 29,026
Separate accounts assets 3,318 5,087
Other assets 4,849 4,714
Total assets 231,212 232,999
Liabilities:    
Accounts payable 13,925 12,544
Pharmacy claims and discounts payable 19,161 17,330
Health care costs payable 10,351 8,808
Policyholders’ funds 1,642 4,301
Accrued expenses 19,423 17,670
Other insurance liabilities 4,561 1,303
Current portion of operating lease liabilities 1,687 1,646
Current portion of long-term debt 1,363 4,205
Liabilities held for sale 296 0
Total current liabilities 72,409 67,807
Long-term operating lease liabilities 17,174 18,177
Long-term debt 50,848 51,971
Deferred income taxes 3,508 6,270
Separate accounts liabilities 3,318 5,087
Other long-term insurance liabilities 6,175 6,402
Other long-term liabilities 6,769 1,904
Total liabilities 160,201 157,618
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,757 shares issued and 1,315 shares outstanding at September 30, 2022 and 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and capital surplus 48,047 47,377
Treasury stock, at cost: 442 shares at September 30, 2022 and 422 shares at December 31, 2021 (30,326) (28,173)
Retained earnings 54,571 54,906
Accumulated other comprehensive income (loss) (1,609) 965
Total CVS Health shareholders’ equity 70,683 75,075
Noncontrolling interests 328 306
Total shareholders’ equity 71,011 75,381
Total liabilities and shareholders’ equity $ 231,212 $ 232,999